Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.
The effect of melphalan on the growth of 4 different lines of human lung-tumour xenografts has been established. The oat-cell carcinoma was the most sensitive, whereas the adenocarcinoma was the most resistant. Two lines of large-cell anaplastic carcinomas were intermediate in sensitivity. The differences in sensitivity were not reflected in the gross uptake of drug into the tumours. There was, with the exception of the adenocarcinoma line, a marked decrease in uptake per g tumour with increasing tumour size. This was partly caused by a decrease in the vascular supply in the same tumours with increasing tumour size. Extravasation of plasma proteins increased with increasing tumour size in all tumours, but was much less pronounced in the adenocarcinoma than in the other tumour lines. The extracellular volume of the various tumour lines did not vary with tumour size.
D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology; D000818:Animals; D002199:Capillary Permeability; D018288:Carcinoma, Small Cell / Q000378:metabolism / Q000473:pathology; D002460:Cell Line; D004911:Erythrocyte Volume; D005110:Extracellular Space; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000378:metabolism*; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology; D010953:Plasma Volume; D014183:Transplantation, Heterologous
D008558:Melphalan